HEREDITARY RENAL/URINARY CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 40 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Hereditary Renal and Urinary Cancer Panel is designed to detect genetic variants responsible for predisposing syndromes to renal, urothelial, and urinary tract tumors. It includes genes associated with hereditary renal cell carcinoma (VHL, FH, FLCN, MET, SDHB, SDHD, TSC1, TSC2), Birt-Hogg-Dubé syndrome (FLCN), hereditary leiomyomatosis with renal cell carcinoma (FH), Von Hippel-Lindau syndrome (VHL), tuberous sclerosis complex (TSC1, TSC2), and carcinomas associated with impaired DNA repair (MLH1, MSH2, MSH6, PMS2, CHEK2, PTEN). It also covers genes involved in urothelial, papillary, and sarcomatoid tumors (MET, BAP1, PBRM1, TP53). This study allows for precise molecular diagnosis, identification of at-risk carriers, and guidance for personalized cancer surveillance. Genes analyzed: VHL, FH, FLCN, MET, SDHB, SDHD, BAP1, PBRM1, PTEN, TSC1, TSC2, TP53, and others. You can consult the complete list of genes analyzed by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€